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Abstract Current routine MRI examinations rely on the acqui-
sition of qualitative images that have a contrast “weighted” for a
mixture of (magnetic) tissue properties. Recently, a novel ap-
proach was introduced, namely MR Fingerprinting (MRF) with
a completely different approach to data acquisition, post-
processing and visualization. Instead of using a repeated, serial
acquisition of data for the characterization of individual param-
eters of interest, MRF uses a pseudo randomized acquisition that
causes the signals from different tissues to have a unique signal
evolution or ‘fingerprint’ that is simultaneously a function of the
multiple material properties under investigation. The processing
after acquisition involves a pattern recognition algorithm to
match the fingerprints to a predefined dictionary of predicted
signal evolutions. These can then be translated into quantitative
maps of the magnetic parameters of interest. MR Fingerprinting
(MRF) is a technique that could theoretically be applied to most
traditional qualitative MRI methods and replaces them with ac-
quisition of truly quantitative tissue measures. MRF is, thereby,
expected to be much more accurate and reproducible than tradi-
tional MRI and should improve multi-center studies and signif-
icantly reduce reader bias when diagnostic imaging is per-
formed.
Key Points
• MR fingerprinting (MRF) is a new approach to data
acquisition, post-processing and visualization.
• MRF provides highly accurate quantitative maps of T1, T2,
proton density, diffusion.
• MRF may offer multiparametric imaging with high
reproducibility, and high potential for multicenter/
multivendor studies.
Keywords Magnetic resonance (MR) .Magnetic resonance
fingerprinting . QuantitativeMR imaging .Multiparametric
MR imaging
Overview
Magnetic resonance (MR) techniques such as MR spectrosco-
py and MRI are widely used throughout physics, biology and
medicine because of their ability to generate detailed informa-
tion about numerous important material or tissue properties,
including those reflective of many common disease states [1,
2]. Tissues in the human body can be distinguished with mag-
netic resonance imaging (MRI) depending on their MR pa-
rameters, such as the longitudinal T1 relaxation, the transverse
T2 relaxation, and the proton density (PD). In clinical routine,
the MR system settings, such as echo time (TE), repetition
time (TR), and flip angle, are most often chosen to highlight,
or saturate, the image intensity of tissues, resulting in T1-
weighting or T2-weighting in an image defined by such a
contrast. There has therefore been a drive to quantitative MR
imaging such as calculation of T1 and T2 relaxation times and
ADC values from diffusion weighted imaging to develop im-
aging biomarkers that complement subjective radiological as-
sessment [3]. However, the MR signal intensity is almost nev-
er quantitative by itself. The same material can have different
intensities in different data sets depending on many factors,
including the type and set-up of the scanner and coils used (B0
and B1 heterogeneities, RF pulse profiles), protocol related
issues such as vulnerability to parameter changes, reconstruc-
tion issues such as noise floor, echo spacing etc., calibration
issues (phantoms) and others. Because of this, in clinical MRI
today, a tissue or material is typically referred to as being
‘hyperintense’ or ‘hypointense’ compared to another area,
whichmay not provide a quantitative indication of the severity
of the differences, and may have reduced sensitivity to global
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changes. A major disadvantage of using such comparisons is
that the absolute intensity has no direct meaning and diagnosis
relies on comparison with surrounding tissues in the image.
Quantitative analysis of MR parameters on the other hand has
so far been largely used to determine differences between
spectral peaks, spatial locations or different points in time.
Thus robust, fully quantitative multi-parametric acquisition
has long been the goal of research in MR. However, the quan-
titative methods developed to date typically provide informa-
tion on a single parameter at a time, require a relatively long
scan time, and are often highly sensitive to system character-
istics. Simultaneous, multi-parametric measurements are al-
most always impractical owing to scan time limits and a high
sensitivity to the measurement set-up and experimental con-
ditions. Therefore the development of imaging biomarkers in
MR and their widespread use in multi-centre studies has posed
a big problem due to the enormous challenge of standardiza-
tion in MR.
An even more definitive approach is the absolute quantifi-
cation of the tissue parameters T1, T2, and PD. In this case,
pathology can be examined on a pixel basis to establish the
absolute deviation compared to the normal values. Automatic
segmentation of such tissue images would be straightforward
and the progress of the disease could then be expressed in
absolute numbers. Although the advantages of absolute quan-
tification are obvious, its clinical use is still limited. At least
two major hurdles need to be addressed to stimulate wide-
spread clinical use. For many methods, the excessive scan
time associated with the measurement of the three parameters
has so far prohibited its clinical application. However, in re-
cent years there has been substantial progress for absolute
quantification of T1, T2, PD of a whole volume with high
resolution in a mere 5 min [4, 5]. The second hurdle, which
must not be underestimated, is the clinical evaluation of the
images. So far, there is only limited experience in using abso-
lute T1, T2, and PD maps in clinical routines and most radi-
ologists will want to confirm their findings using
conventionally-weighted contrast images. The quantification
scan might then be considered as superfluous in the limited
time available for an examination. This item is addressed
using the approach of synthetic MRI. It is possible to synthe-
size any T1-weighted or T2-weighted contrast image based on
the absolute parameters, by calculating the expected image
intensity as a function of a virtual set of scanner settings.
Synthetic MRI can be seen as a translation of the absolute
maps into conventional contrast images; thus, a single quan-
tification scan can provide both the absolute maps and the
contrast images for the examination.
Recently, a novel approach was introduced, namely MR
Fingerprinting (MRF) [6] that may overcome these constraints
by taking a completely different approach to data acquisition,
post-processing and visualization. Instead of using a repeated,
serial acquisition of data for the characterization of individual
parameters of interest, MRF uses a pseudo randomized acqui-
sition that causes the signals from different tissues to have a
unique signal evolution or ‘fingerprint’ that is simultaneously
a function of the multiple material properties under investiga-
tion. The processing after acquisition involves a pattern rec-
ognition algorithm to match the fingerprints to a predefined
dictionary of predicted signal evolutions. These can then be
translated into quantitative maps of the magnetic parameters
of interest.
MRF is related to the concept of compressed sensing [7],
and shares many of its predicted benefits. For example, pre-
liminary results show that MRF could acquire fully quantita-
tive results in a time comparable to a traditional qualitative
MR scan, without the high sensitivity to measurement errors
found inmany other fast methods.Most importantly, MRF has
the potential to quantitatively examine many MR parameters
simultaneously given enough scan time, whereas current MR
techniques can only examine a limited set of parameters at
once [8]. Thus MRF opens the door to computer-assisted
multi-parametric MR analyses, similar to genomic or proteo-
mic analyses that could detect important but complex changes
across a large number of MR parameters simultaneously.
When an appropriate pattern recognition algorithm is used,
MRF also provides a new and more robust behaviour in the
presence of noise or other acquisition errors that may lead to
the near complete suppression of deleterious effects stemming
from these factors.
MR fingerprinting method description
An inversion recovery based steady-state free precession MR
sequence is proposed, since this sequence type is particularly
sensitive to changes in T1, T2, and off-resonance frequencies
and provides the highest signal-to-noise ratio [6, 9]. For signal
readout, a fast sampling trajectory based on variable density
spiral readout is applied and spatial undersampling used to
speed-up measurement times. MRF acquisition patterns with
randomized excitation flip angels, repetitions times, echo
times, and inversion times, would fulfil the compressed sens-
ing criteria for sparse reconstruction. Several slices (~10
slices) with 20 % slice gap and 3-5 mm slice thickness would
cover the major pathological region and provide sufficient
coverage representative for different regions. Automatic posi-
tioning would be performed by established scanner software
(i.e., Auto align) to ensure comparable positing of slices for
reproducibility measurements in healthy volunteers. Repro-
ducibility scans can be performed consecutively in the same
measurement session. The spatial resolution of the acquired
images requires at least a 256×256 matrix with <1.3 mm iso-
tropic resolution. The scan time requirements for MRF can be
~25 sec per acquired slice and an exact optimization of the
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parameter settings done at the outset. A total number of ~3000
excitations results in a total MRF scan time below 10 minutes.
In addition to MRF, conventional MR techniques during
the study examination can be performed for three purposes:
topographic comparison of MRF and traditional routine MR
sequences and localization of the pathologic region.
These routine MR sequences will include short prescans
including localizer sequences, Autoalign sequences for posi-
tioning, MR field map sequences for optimization of B0 field
homogeneities, assessment of B1 homogeneity, and qualita-
tive methods such as fluid-attenuated inversion recovery
(FLAIR), T2-weighted turbo spin echo sequences, as well as
established quantitative MR sequences for measurements of
T1 and T2 such as multi-contrast spin echo based sequences
and fast double inversion recovery based MR sequences [6, 8,
9]. The overall imaging time of the routine MR sequences
should be below 30 min.
Data processing
MRF data processing is performed online at the MR scanner
based on a dedicated “fingerprinting dictionary” [6]. This dic-
tionary was determined based on the MRF sequence setup
(i.e., timing, flip angles etc.) and based on known develop-
ment of spin evolutions during the MR sequence evolution
using the Bloch equations. Matching of the measured data
with the MRF dictionary is performed voxel-vise based on
least squares correlation. The dictionary has to be setup to
match the natural T1, T2, proton density, and off-resonance
distributions that are routinely expected for in vivo MR scans
at 1.5 T MR Scanners.
Meanwhile in addition to T1 and T2 relaxation times, pro-
ton density, and off-resonance distributions new reports dem-
onstrate the possibility of acquiring diffusion property data
and perfusion information by MRF [9, 10]. This opens the
door for a completely new approach towards imaging bio-
markers in many applications of MRI, such as neuro, oncolo-
gy, musculoskeletal, cardiovascular, metabolism and chest.
Conclusion
MRF could theoretically be applied to most traditional quali-
tative MRI methods and may replace them with acquisition of
truly quantitative tissue measures. MRF is expected to be
much more accurate and reproducible than traditional MRI
and should improve multi-centre studies and significantly
reduce reader bias when diagnostic imaging is performed. In
addition, this new approach with MRF has potential to pro-
vide highly reproducible, accurate and fast quantitative imag-
ing of several MR parameters simultaneously, and allow de-
velopment of reliable and standardized imaging biomarkers
and their multi parametric combinations, which can be vali-
dated in multicenter studies because of their good reproduc-
ibility across sites and even across different MR vendors.
Acknowledgments This article was kindly prepared by the ESR Sub-
committee on Imaging Biomarkers (Chair and lead/corresponding author:
Siegfried Trattnig, Members: Olivier Clément, Nandita de Souza, Marco
Essig, Thomas Helbich, Hans-Ulrich Kauczor, Fabian Kiessling, Celso
Matos, Wiro Niessen, Harriet C. Thoeny, Jean-Paul Vallée, Edwin van
Beek, Aad van der Lugt, Valérie Vilgrain) on behalf of the European
Society of Radiology (ESR). It was approved by the ESR Executive
Council on February 19, 2015.
Open Access This article is distributed under the terms of the Creative
Commons Attribution License which permits any use, distribution, and
reproduction in any medium, provided the original author(s) and the
source are credited.
References
1. Filippi M, Absinta M, Rocca MA (2013) Future MRI tools in multi-
ple sclerosis. J Neurol Sci 331:14–18
2. Larsson HB, Frederiksen J, Petersen J, Nordenbo A, Zeeberg I,
Henriksen O, Olesen J (1989) Assessment of demyelination, edema,
and gliosis by in vivo determination of T1 and T2 in the brain of
patients with acute attack of multiple sclerosis. Magn Reson Med 11:
337–348
3. E.S.o.R. (ESR) (2013) ESR statement on the stepwise development
of imaging biomarkers. Insights Imaging 4:147–152
4. Warntjes JBM, Dahlqvist P, Leinhard O, West J, Lundberg P (2008)
Optimization for Clinical Usage of Rapid Magnetic Resonance
Quantification on the brain. Magn Reson Med 60:320–329
5. Warntjes JBM, Dahlqvist O, Lundberg P (2008) Novel Method for
Rapid, Simultaneous T1, T*2, and Proton Density Quantification.
Magn Reson Med 57:528–537
6. Ma D, Gulani V, Seiberlich N, Liu K, Sunshine JL, Duerk JL,
Griswold MA (2013) Magnetic resonance fingerprinting. Nature
495:187–192
7. Lustig M, Donoho D, Pauly JM (2007) Sparse MRI: The application
of compressed sensing for rapid MR imaging. Magn Reson Med 58:
1182–1195
8. Deoni SC, Peters TM, Rutt BK (2005) High-resolution T1 and T2
mapping of the brain in a clinically acceptable time with DESPOT1
and DESPOT2. Magn Reson Med 53:237–241
9. Schmitt P, Griswold MA, Jakob PM, Kotas M, Gulani V, Flentje M,
Haase A (2004) Inversion recovery TrueFISP: quantification of T(1),
T(2), and spin density. Magn Reson Med 51:661–667
10. Crawley AP, Henkelman RM (1988) A comparison of one-shot and
recovery methods in T1 imaging. Magn Reson Med 7:23–34
Insights Imaging (2015) 6:163–165 165
